Get startedLog in
    Picture of Oncopeptides AB logo

    ONCO — Oncopeptides AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Oncopeptides Presents Phase 3 Ocean Study Results At IMW Meeting

    Picture of Oncopeptides AB logoOncopeptides AB
    11/09/2021 10:09
    Sept 11 (Reuters) - Oncopeptides AB  ONCO.ST :
    * ONCOPEPTIDES PRESENTS PHASE 3 OCEAN STUDY RESULTS AT IMW
MEETING
    * MELFLUFEN MET PRIMARY ENDPOINT OF SUPERIOR PROGRESSION
FREE
SURVIVAL (PFS) AS ASSESSED BY INDEPENDENT REVIEW COMMITTEE (IRC)

Source text for Eikon:  ID:nWkr9PZT7G 
Further company coverage:  ONCO.ST 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Oncopeptides AB

    See all news